Business Context and Reporting Period
This Form 8-K Current Report was filed by Amphastar Pharmaceuticals, Inc. on August 19, 2021. The report discloses a corporate governance event regarding the departure of a director.
Financial Metrics
This filing does not contain financial data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
The material change disclosed is the resignation of David Maris from the Board of Directors, effective immediately on August 19, 2021. The Company stated that the resignation is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Management commentary is limited to expressing appreciation for Mr. Maris's service and contributions.
Key Facts for Investor Verification
- David Maris resigned from the Board of Directors effective August 19, 2021.
- The resignation was not caused by any disagreement with the Company.
- The report was signed by William J. Peters, Chief Financial Officer and Executive Vice President.
- No financial performance data is included in this specific filing.